Evidence map›Paper›PMID 34293228›Full record

ArticleAngewandte Chemie (International ed. in English)2021

Controlling Coagulation in Blood with Red Light.

Patricia Müller, Marlen Sahlbach, Simone Gasper, Günter Mayer, Jens Müller, Bernd Pötzsch, Alexander Heckel

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Controlling Coagulation in Blood with Red Light.Angewandte Chemie (International ed. in English) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Patricia MüllerGoethe University Frankfurt, Institute for Organic Chemistry and Chemical Biology, Max-von-Laue Str. 9, 60438, Frankfurt am Main, Germany.
Marlen SahlbachGoethe University Frankfurt, Institute for Organic Chemistry and Chemical Biology, Max-von-Laue Str. 9, 60438, Frankfurt am Main, Germany.
Simone GasperUniversity Hospital Bonn, Institute of Experimental Hematology and Transfusion Medicine, Venusberg-Campus 1, 53105, Bonn, Germany.
Günter MayerUniversity of Bonn, Life and Medical Sciences Institute, Center of Aptamer Research & Development, Gerhard-Domagk-Str. 1, 53121, Bonn, Germany.
Jens MüllerUniversity Hospital Bonn, Institute of Experimental Hematology and Transfusion Medicine, Venusberg-Campus 1, 53105, Bonn, Germany.ORCID 0000-0001-7713-9631
Bernd PötzschUniversity Hospital Bonn, Institute of Experimental Hematology and Transfusion Medicine, Venusberg-Campus 1, 53105, Bonn, Germany.
Alexander HeckelGoethe University Frankfurt, Institute for Organic Chemistry and Chemical Biology, Max-von-Laue Str. 9, 60438, Frankfurt am Main, Germany.ORCID 0000-0003-3541-4548

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precise control of blood clotting and rapid reversal of anticoagulation are essential in many clinical situations. We were successful in modifying a thrombin-binding aptamer with a red-light photocleavable linker derived from Cy7 by Cu-catalyzed Click chemistry. We were able to show that we can successfully deactivate the modified aptamer with red light (660 nm) even in human blood-restoring the blood's natural coagulation capability.

Indexed as

LightAnticoagulantsBenzothiazolesBlood CoagulationCarbocyaninesHumansMolecular StructureAnticoagulantsBenzothiazolesCarbocyaninescyanine dye 7aptameroligonucleotidephotocagingphototherapeutic windowred light

Identifiers

PMID34293228
PMCPMC8518524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.